Drug Channels Archive for December, 2017

Click a link below to view the mailing archive as if it had been sent to you.

2017-12-22 07:39Drug Channels - Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars (rerun)
2017-12-21 07:33Drug Channels - Why Manufacturers and PBMs Should Worry About the Growth of Hospital-Owned Specialty Pharmacies (rerun)
2017-12-20 07:36Drug Channels - Follow the Dollar Math: How Much Do Pharmacies, Wholesalers, and PBMs Make From a Prescription? (rerun)
2017-12-19 07:49Drug Channels - Drug Channels Outlook: What to Watch in 2018
2017-12-18 07:46Drug Channels - CBI’s 5th Annual Reimbursement & Contracting Conference
2017-12-15 07:34Drug Channels - Life Sciences Market Access & Commercialization (LSMAC) Summit
2017-12-14 08:00Drug Channels - 2016 Drug Spending: The Shift from Employers to Government Payers—And Troubling Trends For Patients
2017-12-12 07:38Drug Channels - CMS Confirms It: Drug Spending Slows, Hospital and Physician Spending Grows
2017-12-11 07:34Drug Channels - sPCMA Business Forum 2018
2017-12-08 07:25Drug Channels - Triplefin: How An Independent Service Provider Is Positioning for Growth
2017-12-07 07:46Drug Channels - Five Industry Trends for U.S. Drug Wholesalers in 2018
2017-12-05 07:45Drug Channels - The CVS-Aetna Deal: Five Industry and Drug Channel Implications
2017-12-04 07:31Drug Channels - CBI’s 10th Hub and SPP Model Optimization


<< Archive IndexSubscribe >>